Geron (GERN) Cash & Equivalents (2010 - 2026)
Geron recorded quarterly Cash & Equivalents of $1.9 million in Q1 2026, little changed quarter-over-quarter from $1.9 million in Q4 2025, and down 97.75% year-over-year from $83.7 million in Q1 2025.
Geron's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 97.75% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 97.75% YoY), while the FY2025 annual figure was $1.9 million, up 1.08% from the prior year.
- Cash & Equivalents came in at $1.9 million for Q1 2026 at Geron, roughly flat from $1.9 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $112.8 million in Q1 2023 to a low of $364000.0 in Q1 2022.
- A 5-year average of $33.5 million and a median of $1.9 million in 2026 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents plunged 99.36% in 2022 and surged 30882.69% in 2023, its largest moves.
- Geron's Cash & Equivalents stood at $56.8 million in 2022, then rose by 23.18% to $70.0 million in 2023, then tumbled by 97.34% to $1.9 million in 2024, then gained by 1.08% to $1.9 million in 2025, then rose by 0.21% to $1.9 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $1.9 million, $1.9 million, and $78.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Geron | 856,799.98 | 856,799.98 | - | 1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 78.12 Mn |
| Jun 30, 2025 | 38.78 Mn |
| Mar 31, 2025 | 83.75 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 70.02 Mn |
| Sep 30, 2023 | 536,000.00 |
| Jun 30, 2023 | 56.90 Mn |
| Mar 31, 2023 | 112.78 Mn |
| Dec 31, 2022 | 56.85 Mn |
| Sep 30, 2022 | 61.10 Mn |
| Jun 30, 2022 | 364,000.00 |
| Mar 31, 2022 | 364,000.00 |
| Dec 31, 2021 | 34.87 Mn |
| Sep 30, 2021 | 363,000.00 |
| Jun 30, 2021 | 57.28 Mn |
| Mar 31, 2021 | 363,000.00 |
| Dec 31, 2020 | 363,000.00 |
| Sep 30, 2020 | 44.96 Mn |
| Jun 30, 2020 | 363,000.00 |
| Mar 31, 2020 | 270,000.00 |
| Dec 31, 2019 | 13.64 Mn |
| Sep 30, 2019 | 270,000.00 |
| Jun 30, 2019 | 270,000.00 |
| Mar 31, 2019 | 6.80 Mn |
| Dec 31, 2018 | 10.58 Mn |
| Sep 30, 2018 | 269,000.00 |
| Jun 30, 2018 | 19.13 Mn |
| Mar 31, 2018 | 7.91 Mn |
| Dec 31, 2017 | 268,000.00 |
| Sep 30, 2017 | 9.90 Mn |
| Jun 30, 2017 | 6.61 Mn |
| Mar 31, 2017 | 14.86 Mn |
| Dec 31, 2016 | 12.81 Mn |
| Sep 30, 2016 | 5.88 Mn |
| Jun 30, 2016 | 8.20 Mn |
| Mar 31, 2016 | 12.80 Mn |
| Dec 31, 2015 | 21.25 Mn |
| Sep 30, 2015 | 16.82 Mn |
| Jun 30, 2015 | 15.80 Mn |
| Mar 31, 2015 | 10.18 Mn |
| Dec 31, 2014 | 42.80 Mn |
| Sep 30, 2014 | 7.60 Mn |
| Jun 30, 2014 | 9.52 Mn |
| Mar 31, 2014 | 11.32 Mn |
| Dec 31, 2013 | 12.99 Mn |
| Sep 30, 2013 | 9.59 Mn |
| Jun 30, 2013 | 8.83 Mn |
| Mar 31, 2013 | 15.51 Mn |
| Dec 31, 2012 | 22.06 Mn |
| Sep 30, 2012 | 16.01 Mn |
| Jun 30, 2012 | 14.12 Mn |
| Mar 31, 2012 | 19.03 Mn |
| Dec 31, 2011 | 16.11 Mn |
| Sep 30, 2011 | 33.98 Mn |
| Jun 30, 2011 | 32.02 Mn |
| Mar 31, 2011 | 35.41 Mn |
| Dec 31, 2010 | 45.97 Mn |
| Sep 30, 2010 | 34.49 Mn |
| Jun 30, 2010 | 37.32 Mn |